Free US stock correlation to major indices and sector benchmarks for performance attribution analysis. We help you understand how your portfolio moves relative to broader market benchmarks.
As of 2026-04-13, Relay Therapeutics Inc. (RLAY) trades at a current price of $15.21, marking a 1.81% gain in recent sessions. The clinical-stage biotechnology company, which focuses on leveraging protein dynamic research to develop targeted therapies for hard-to-treat diseases, has seen muted but steady price action in recent weeks, trading within a well-defined range as market participants weigh broader sector sentiment and upcoming potential pipeline milestones. This analysis outlines key tec
Will Relay Therapeutics (RLAY) Stock Recover Soon | Price at $15.21, Up 1.81% - High Conviction Picks
RLAY - Stock Analysis
4926 Comments
1267 Likes
1
Aceyn
Senior Contributor
2 hours ago
Missed the timing… sadly.
👍 154
Reply
2
Yeimy
Consistent User
5 hours ago
Technical indicators suggest a continuation of the current trend.
👍 102
Reply
3
Hamnah
Legendary User
1 day ago
This feels like an unfinished sentence.
👍 131
Reply
4
Analisha
Engaged Reader
1 day ago
Market participants are cautiously optimistic, awaiting further economic or corporate developments.
👍 283
Reply
5
Magee
Senior Contributor
2 days ago
This confirms I acted too quickly.
👍 237
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.